Sign In
News Digest /
Ticker: LLY
Ticker: LLY
04:06am, Wednesday, May 06, 2026
Novo Nordisk stock jumps on stronger-than-expected Wegovy pill sales and upgraded 2026 guidance amid growing market share in the competitive U.S. weight-loss drug sector.
04:29am, Tuesday, May 05, 2026
Novo Nordisk's Wegovy pill sales are climbing fast, but rising competition and falling prices in obesity drugs, especially from Eli Lilly's new Foundayo, are putting pressure on revenue growth and market expectations.
08:46am, Thursday, Apr 30, 2026
Eli Lilly outperformed expectations in Q1 thanks to soaring sales of weight loss drug Zepbound and diabetes treatment Mounjaro. The company trims full-year revenue guidance upward amid strong demand momentum.
08:24am, Wednesday, Apr 29, 2026
As Eli Lilly rolls out its weight-loss drug Foundayo, investors await clear sales data. Early reports suggest a slower uptake compared to rivals, but comprehensive insights remain weeks away.
11:16am, Wednesday, Mar 18, 2026
AbbVie and Philip Morris stocks slip amid broader market shifts, while names like GE Vernova, Regencell, and Lumentum post notable gains in a day marked by mixed moves across mega, large, mid, and small caps.
07:41am, Monday, Feb 09, 2026
Innovent Biologics inks deal with Eli Lilly to co-develop cancer and immune disease treatments, setting stage for up to $8.5B in milestones and exclusive global rights for Lilly outside China.
08:03am, Wednesday, Feb 04, 2026
Novo Nordisk's stock tumbled following a lowered 2026 sales outlook impacted by U.S. price cuts and patent expirations, signaling challenges ahead despite 2025 growth.
07:11am, Wednesday, Jan 28, 2026
Novo Nordisk poured nearly $500M into US ads for Wegovy and Ozempic in early 2025, spending more than twice as much as Eli Lilly on competing obesity and diabetes drugs.
06:08am, Monday, Jan 12, 2026
Shares of Abivax (EPA: ABVX) leap over 23% following reports that Eli Lilly (NYSE: LLY) is eyeing a billion-euro acquisition, stirring chatter on a potential mega-deal in biotech.
09:11am, Thursday, Dec 11, 2025
Eli Lilly's latest weight-loss medication has been found to reduce knee osteoarthritis pain, marking a potential breakthrough for patients suffering from joint pain linked to obesity.
08:05am, Thursday, Nov 13, 2025
Telehealth player Mangoceuticals partners with Eli Lilly and Novo Nordisk, launching digital programs to sell blockbuster GLP-1 weight-loss drugs, sparking a 32% jump in its shares.
08:33am, Wednesday, Nov 05, 2025
Wall Street futures edged down amid anxiety over stretched valuations and mixed earnings reports from chipmakers and insurers, with traders watching closely ahead of key U.S. jobs data and ongoing government shutdown tensions.
08:39am, Thursday, Oct 30, 2025
Eli Lilly beats earnings and revenue forecasts as sales of Zepbound and Mounjaro skyrocket, prompting a boost in full-year guidance amid fierce competition with Novo Nordisk in the GLP-1 drug market.
08:56am, Friday, Oct 24, 2025
Novo Nordisk's board upheaval hands chairman Lars Rebien Sørensen unmatched authority amid market share slump and competition surge from Eli Lilly, stirring investor unease and governance debate.
08:03am, Monday, Oct 06, 2025
Eli Lilly (LLY) to invest over $1B in India to ramp drug manufacturing via contract partners, open a Hyderabad manufacturing & quality hub and hire technical staff-aiming to ease supply gaps amid U.S. tariffs and rising GLP‑1 generic competition.
09:21am, Friday, Sep 26, 2025
Premarket: tariff chatter lifts chips & pharma-Intel (INTC) +3.7%, GlobalFoundries (GFS) jumps; J&J (JNJ), Pfizer, Lilly firmer after 100% branded-drug tariff talk. Boeing (BA) up on orders; Wayfair (W) down on furniture tariffs. Volatility likely.
07:31am, Monday, Sep 22, 2025
Pfizer to Buy Metsera for Up to $7.3B - $47.50/Share Cash (43% Premium), Metsera Pops ~56% Premarket
Pfizer to buy Metsera for up to $7.3B - $47.50/share plus $22.50 in milestones (~43% premium). Metsera jumped ~56% premarket. Deal fast-tracks Pfizer into the obesity drug race with Eli Lilly and Novo Nordisk.
03:49am, Wednesday, Sep 17, 2025
GSK pledges $30B and Eli Lilly $5B for U.S. manufacturing to expand biologics capacity and hedge against potential import levies-part of a $350B industry onshoring push that could reshape margins, supply chains and jobs.
02:35am, Wednesday, Sep 10, 2025
Novo Nordisk to cut ~9,000 jobs (11.5%) to save DKK8bn (~$1.26bn); DKK9bn restructuring hit trims operating profit growth guidance to 4-10% (from 10-16%). Wegovy/Ozempic face Eli Lilly competition; shares down ~46% YTD.
06:21am, Friday, Aug 29, 2025
Denmark cuts 2025 GDP to 1.4% (from 3%) as Novo Nordisk's GLP‑1 slowdown and US tariff-hit exports weigh; export growth trimmed to 0.9% (from 4.3%). 2026 GDP forecast raised to 2.1%.
02:57am, Wednesday, Aug 20, 2025
Viking Therapeutics (VKTX) plunged ~37% after Phase 2 VENTURE showed VK2735 met its primary endpoint-up to 12.2% weight loss at 13 weeks-but a 28% discontinuation rate and GI side effects spurred adoption worries; Eli Lilly (LLY) edged up.
07:36am, Friday, Aug 08, 2025
European stocks rose 0.2%, marking their biggest weekly gain in three months as Novo Nordisk surged 4.6% on strong obesity drug data. Positive earnings and Fed rate cut bets boosted markets, despite weakness in German insurers and Eli Lilly shares.
07:02am, Wednesday, Aug 06, 2025
Trump's tariff moves reshape global trade, easing EU tensions but hiking duties on copper and low-value imports. Key deadlines in August-September may escalate US-China friction and pressure drugmakers like Eli Lilly and Pfizer on pricing.
12:02pm, Thursday, May 01, 2025
Company Overview
Eli Lilly and Company (NYSE: LLY) reported its Q1 2025 financial results, demonstrating significant growth both in revenue and net income. The company is heavily engaged in pharmaceutical research and development, with a focus on therapeutic areas like cardiometabolic health, onc...
05:41am, Wednesday, Apr 30, 2025
Merck & Co. plans to invest $1 billion in a Delaware manufacturing plant, enhancing domestic production and creating 4,000 jobs. This facility will produce Keytruda, bolstering Merck's supply chain amid tariff pressures, marking a key move in U.S. pharma manufacturing.
07:07am, Monday, Apr 28, 2025
Over 20 major companies report earnings this week, including 5 from the Magnificent Seven—Apple, Amazon, Microsoft, Meta, and more. Plus, watch key economic updates like Q1 GDP and PCE that could spark big market moves
07:56am, Thursday, Apr 17, 2025
Eli Lilly (NYSE: LLY) shares soared 12.5% after positive Phase 3 trial results for orforglipron, an oral type 2 diabetes treatment. The drug showed significant glycemic improvements and weight loss benefits, with more trials underway, indicating potential long-term growth.
09:59am, Friday, Mar 21, 2025
Johnson & Johnson (NYSE: JNJ) plans to invest over $55 billion in U.S. manufacturing, unveiling four new plants, starting with a $2 billion facility in North Carolina. This move responds to potential drug import tariffs, signaling a trend in domestic production.
03:44am, Monday, Feb 24, 2025
Amgen (NASDAQ: AMGN) invests $200 million in a new tech center in Hyderabad, India, focusing on AI and data science for drug development. This move enhances its market presence and aligns with U.S.-India trade talks. Traders should monitor its growth potential.
04:38pm, Thursday, Feb 06, 2025
The S&P 500 rose 0.3% while the NASDAQ gained 0.5% amid volatile trading influenced by earnings reports and labor market signals. Traders brace for key jobs data, amid mixed corporate performances, especially in tech stocks. Stay alert for market shifts!
09:28am, Monday, Feb 03, 2025
Investors eagerly await earnings reports this week from key players like Google, Toyota, Amazon, Alibaba, Eli Lilly, and Merck. These results will provide critical insights into the technology, automotive, and pharmaceutical sectors, influencing market dynamics.
08:56am, Tuesday, Dec 10, 2024
Tuesday Markets are steady as Nvidia faces China probe, Tesla sued over Autopilot crash, GameStop readies Q3 report, and EU probes Google over teen ad deal.
06:14am, Tuesday, Nov 05, 2024
EU regulators will decide by December 6 on Novo Holdings’ acquisition of Catalent. The deal, vital for expanding obesity drug production, faces scrutiny from both EU and U.S. bodies, potentially reshaping the competitive pharmaceutical landscape.
09:41am, Wednesday, Oct 30, 2024
Wednesday Markets: Nasdaq gains on tech rally, boosted by robust private payroll growth. Upcoming tech earnings and ADP employment data signal market trends.
04:20am, Monday, Oct 28, 2024
Key earnings reports are set for the week of October 28, 2024, with major players like Google, Microsoft, Apple, and Amazon revealing crucial financials. Investors should stay alert for potential market shifts following these announcements.
06:22am, Monday, Oct 21, 2024
Eli Lilly (NYSE: LLY) has filed lawsuits against online vendors and a medical spa for unauthorized sales of products claiming to contain tirzepatide, its weight-loss drug Zepbound. The legal actions aim to protect public health and consumer safety amid recent FDA developments.
08:26am, Wednesday, Oct 02, 2024
Before markets open, GM reports a boost in EV sales, Nike shares drop on mixed earnings, and Eli Lilly announces a $4.5B investment in U.S. manufacturing.
06:35am, Tuesday, Sep 24, 2024
Novo Nordisk CEO Lars Jorgensen faces scrutiny from Senator Bernie Sanders over high U.S. prices for Ozempic and Wegovy, with cash costs exceeding $1,000 monthly. In response, Jorgensen cites R&D investments and favorable insurance coverage, while market dynamics evolve.
09:30am, Monday, Sep 16, 2024
These 2 stocks show long-term potential in the healthcare sector. Learn why these stocks are gaining attention and what investors should consider.